BNT324/DB-1311 showed encouraging antitumor activity and a manageable safety profile in a Phase 1/2a clinical trial in heavily pretreated patients with locally advanced or metastatic solid tumors, including small cell lung cancer (“SCLC”), non-small cell lung cancer (“NSCLC”), and…

NEW YORK, Dec. 5, 2024 /PRNewswire/ — PEI Global Partners (“PEI”) is pleased to announce that Project Trident has been awarded the prestigious “Power & Transmission Acquisition of the Year – North America” honor at the IJInvestor Awards 2024. The IJInvestor Awards celebrate achievements…

NEW YORK, Dec. 5, 2024 /PRNewswire/ — Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of WM Technology, Inc. (NASDAQ: MAPS) between May 25, 2021, and September 24, 2024, both dates inclusive (the “Class Period”), of the important December 16, 2024…

Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.